An error occurred during the execution of a web request, resulting in an unhandled exception. The exception was a System.FormatException, which indicates that the input string was not in the correct format. This error occurred in the Page_Load method of the NewsDetails.aspx.cs file, specifically on line 140.<\/p>\n
The stack trace provides more information about the origin and location of the exception. It shows that the error occurred in the Pharmabiz.NewsDetails.Page_Load method, which is part of the NewsDetails.aspx.cs file. The method is called when the page is loaded, and it is responsible for initializing the page and its controls.<\/p>\n
The error is likely due to the fact that the input string is not in the correct format, which is causing the Page_Load method to fail. The exact cause of the error is not specified, but it could be due to a variety of factors, such as invalid user input, incorrect data formatting, or a bug in the code.<\/p>\n
The version information provided shows that the error occurred on a server running Microsoft.NET Framework version 4.0.30319 and ASP.NET version 4.8.4676.0. This information can be useful for debugging and troubleshooting purposes.<\/p>\n
To resolve the error, the developer will need to review the code and identify the cause of the exception. This may involve checking the input data, validating user input, and ensuring that the data is in the correct format. Additionally, the developer may need to modify the code to handle exceptions and errors more robustly, to prevent similar errors from occurring in the future.<\/p>\n
In general, a System.FormatException is a common error that can occur when working with strings and data formatting. It is often caused by incorrect or invalid data, and can be resolved by validating and sanitizing user input, and ensuring that data is in the correct format before attempting to process it. By reviewing the code and identifying the cause of the exception, the developer can take steps to resolve the error and prevent it from occurring again in the future.<\/p>\n","protected":false},"excerpt":{"rendered":"
An error occurred during the execution of a web request, resulting in an unhandled exception. The exception was a System.FormatException, which indicates that the input string was not in the correct format. This error occurred in the Page_Load method of the NewsDetails.aspx.cs file, specifically on line 140. The stack trace provides more information about the […]<\/p>\n","protected":false},"author":1,"featured_media":88041,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","fifu_image_url":"","fifu_image_alt":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-89711","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dr-reddys"],"jetpack_featured_media_url":"https:\/\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":89757,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/06\/sun-pharmaceutical-industries-suffers-loss-in-trademark-dispute-as-bombay-high-court-rules-esiraft-and-raciraft-do-not-bear-deceptive-similarities\/","url_meta":{"origin":89711,"position":0},"title":"Sun Pharmaceutical Industries suffers loss in trademark dispute as Bombay High Court rules EsiRaft and Raciraft do not bear deceptive similarities.","author":"Team Small News","date":"January 6, 2026","format":false,"excerpt":"The Bombay High Court has ruled in favor of Eris Lifesciences, dismissing Sun Pharmaceutical's claim that Eris's medication \"EsiRaft\" infringed on Sun Pharma's trademark for their medication \"Raciraft\". The court found that the names \"EsiRaft\" and \"Raciraft\" are not deceptively similar, and therefore, Eris Lifesciences did not infringe on Sun\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":89747,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/04\/tragedy-strikes-in-bengaluru-as-26-year-old-biocon-staff-member-takes-fatal-leap-from-5th-floor-of-office-building\/","url_meta":{"origin":89711,"position":1},"title":"Tragedy strikes in Bengaluru as 26-year-old Biocon staff member takes fatal leap from 5th floor of office building.","author":"Team Small News","date":"January 4, 2026","format":false,"excerpt":"A 26-year-old employee of Biocon, a biopharmaceutical company, jumped to his death from the 5th floor of the company's office building in Bengaluru, India. The incident occurred on a recent day, and the police are currently investigating the circumstances surrounding the death. According to reports, the employee, whose identity has\u2026","rel":"","context":"In "Biocon"","block_context":{"text":"Biocon","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/biocon\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":89690,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2025\/12\/20\/zydus-lifesciences-partners-with-myriad-genetics-to-introduce-cutting-edge-cancer-diagnostic-solutions-in-india\/","url_meta":{"origin":89711,"position":2},"title":"Zydus Lifesciences Partners with Myriad Genetics to Introduce Cutting-Edge Cancer Diagnostic Solutions in India.","author":"Team Small News","date":"December 20, 2025","format":false,"excerpt":"Zydus Lifesciences Limited, a global life sciences company, has partnered with US-based Myriad Genetics to introduce advanced cancer-risk assessment and prognostic diagnostic tests in India. The exclusive agreement allows Zydus to offer Myriad's MyRisk Hereditary Cancer Test, MyChoice HRD Plus Test, and Prolaris Prostate Cancer Prognostic Test to patients, clinicians,\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/Zydus-Logo.jpg?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":89831,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/21\/dr-reddys-and-eternal-gain-attention-as-kpi-green-witnesses-significant-uptick\/","url_meta":{"origin":89711,"position":3},"title":"Dr Reddy’s and Eternal Gain Attention as KPI Green Witnesses Significant Uptick","author":"Team Small News","date":"January 21, 2026","format":false,"excerpt":"KPI Green Energy Ltd. has reported impressive financial results for the third quarter, with a 39.4% year-over-year increase in net profit to \u20b9118 crore. The company's revenue also saw a significant rise of 44.6% to \u20b9663 crore during the quarter. Additionally, the company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and\u2026","rel":"","context":"In "Dr Reddy's"","block_context":{"text":"Dr Reddy's","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/dr-reddys\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":89737,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/02\/usfda-deals-a-blow-to-dr-reddys-biosimilar-denosumab-avt03-following-an-inspection-of-the-manufacturing-facility\/","url_meta":{"origin":89711,"position":4},"title":"USFDA deals a blow to Dr Reddy’s biosimilar denosumab AVT03 following an inspection of the manufacturing facility.","author":"Team Small News","date":"January 2, 2026","format":false,"excerpt":"Dr. Reddy's Laboratories has faced a setback in its efforts to bring its denosumab biosimilar, AVT03, to the US market. The US Food and Drug Administration (USFDA) has issued a warning letter to the company after conducting an inspection of its manufacturing facility. The inspection revealed several issues with the\u2026","rel":"","context":"In "Dr Reddy's"","block_context":{"text":"Dr Reddy's","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/dr-reddys\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/04\/Dr.Reddys_logo.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":89739,"url":"https:\/\/smallnews.in\/pharmaceuticals\/2026\/01\/02\/sun-pharma-wins-reprieve-as-cestat-sends-back-rs-3-90-crore-excise-demand-for-re-assessment-over-eou-dta-sales-and-deemed-exports-juris-hour\/","url_meta":{"origin":89711,"position":5},"title":"Sun Pharma Wins Reprieve as CESTAT Sends Back Rs. 3.90 Crore Excise Demand for Re-Assessment Over EOU DTA Sales and Deemed Exports – Juris Hour","author":"Team Small News","date":"January 2, 2026","format":false,"excerpt":"The Customs, Excise, and Service Tax Appellate Tribunal (CESTAT) has remanded a Rs. 3.90 crore excise demand against Sun Pharmaceutical Industries Ltd. regarding sales from an Export Oriented Unit (EOU) to a Domestic Tariff Area (DTA). The tribunal has directed the authorities to recalculate the deemed exports and the corresponding\u2026","rel":"","context":"In "Pharma"","block_context":{"text":"Pharma","link":"https:\/\/smallnews.in\/pharmaceuticals\/category\/pharma\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/smallnews.in\/pharmaceuticals\/wp-content\/uploads\/sites\/6\/2025\/05\/sun-pharma-logo.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"_links":{"self":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89711","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/comments?post=89711"}],"version-history":[{"count":0,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/posts\/89711\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media\/88041"}],"wp:attachment":[{"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/media?parent=89711"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/categories?post=89711"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallnews.in\/pharmaceuticals\/wp-json\/wp\/v2\/tags?post=89711"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}